Abstract
Abstract The authors did not submit an updated abstract. The original abstract should be considered final. Citation Format: Christian LaFougere, Brigitte Gueckel, Helmut Dittmann, Martina Hinterleitner, Nils Trautwein, Jonathan Cotton, Gabriele Kienzle, Stephan Singer, Gerald Reischl, Ulrich Lauer, Bernd Pichler, Lars Zender. A phase 1/2, open-label study to assess safety, tolerability, biodistribution, radiation dosimetry and PET imaging characteristics of [18F]FPyGal in comparison to in-vitro diagnostic for the assessment of senescence in oncological patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr CT178.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
